医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mannatech Launches New TruPLENISHTM Nutritional Shake in Australia

2016年08月09日 AM04:02
このエントリーをはてなブックマークに追加


 

SYDNEY

Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, recently launched its newest nutritional fat-loss meal replacement shake, TruPLENISH™, to its Australasian market at its regional Australasian MannaFestSM conference in Sydney.

The TruPLENISH Nutritional Shake is a complete meal replacement drink full of vitamins, minerals, probiotics, glyconutrients and more than 20 grams of plant-based protein. The product supports fat loss and the development of lean muscle when combined with regular exercise and a reduced calorie diet. TruPLENISH comes in delicious chocolate and vanilla flavours.

“We are very excited to bring this excellent product to the Australian market and expand our offering of new products around the globe,” said Mannatech CEO and President, Alfredo “Al” Bala. “Mannatech is leading a new weight management approach by focusing on targeted fat loss and maintaining, if not increasing muscle mass. As a satisfied customer myself, I have seen that TruPLENISH is uniquely designed to help you look better and feel better with our revolutionary fat loss approach.”

Mannatech’s Australian market revealed the TruPLENISH Nutritional Shake to Associates from Australia, New Zealand and Singapore at its regional two-day MannaFest event in Sydney. Hundreds of Associates gather each year to receive the latest company updates and business training to take their Mannatech businesses to the next level.

The TruPLENISH Nutritional Shake is now available for purchase in all three countries and will be made available to other Mannatech markets around the world later this year.

To begin transforming your life or the lives of those around you, please visit Mannatech.com.

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience through a financially rewarding opportunity that makes a difference in the lives of people across the world. Through its innovative glyconutrition products, Mannatech transforms lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in more than 25 countries, Mannatech is committed to transforming lives. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160808006079/en/

CONTACT

Mannatech, Incorporated
Raquel Mooring, 972-471-1532
pr@mannatech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 三井化学开发全球首款灵活的高强度柔性无纺布AIRYFA™
  • APR应用制药研究公司参加第9届ChinaBio®合作论坛:依托瑞士创新产品和科学技术深耕中国市场
  • Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见
  • SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven Separations
  • LMDのV-Sensorがインドでバイタルサインを測定